Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Extracorporeal devices for methods for treating diseases associated with anti-neutrophil cytoplasmic antibodies

Extracorporeal devices for methods for treating diseases associated with anti-neutrophil cytoplasmic antibodies

US Patent 12156959 · Granted Dec 3, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric antigen receptor and CAR-T cells that bind BCMA2025
Chimeric antigen receptor and CAR-T cells that bind BCMA2024
Humanized antibodies against CD269 (BCMA)2023
Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cel2023
Humanized antibodies against CD269 (BCMA)2020
Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cel2020
Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cel2019
Humanized antibodies against CD269 (BCMA)2018